Wei Jiang

机构：Fudan University, Zhongshan Hospital · ORCID：0000-0003-0904-3990

发表论文 150 篇 · 总被引 3347 次 · h-index 35

代表论文

• Targets of tumor microenvironment for potential drug development (2024 · MedComm – Oncology · 被引 54)
• CD24 is a promising immunotherapeutic target for enhancing efficacy of third‐generation EGFR‐TKIs on EGFR‐mutated lung cancer (2025 · 癌症：英文版 · 被引 14)
• Antitumour effects of artesunate via cell cycle checkpoint controls in human oesophageal squamous carcinoma cells (2024 · European journal of medical research · 被引 12)
• Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencing (2024 · eLife · 被引 10)
• Targeting ALDH16A1 mediated thioredoxin lysosomal degradation to enhance ferroptosis susceptibility in SMARCA4-deficient NSCLC (2025 · Nature Communications · 被引 8)
• Applying machine learning to predict bowel preparation adequacy in elderly patients for colonoscopy: development and validation of a web-based prediction tool (2025 · Annals of Medicine · 被引 8)